When tissue is severely damaged, surviving cells can respond in a concentrated burst of biological repair known as ...

AbbVie and RemeGen are collaborating on RC148, a novel PD-1/VEGF-targeted bispecific antibody already being developed as a ...

AbbVie & RemeGen enter exclusive licensing agreement to develop novel bispecific antibody for advanced solid tumours: North Chicago, Illinois Tuesday, January 13, 2026, 14:00 Hrs ...

US pharma major AbbVie and China’s RemeGen today announced an exclusive licensing agreement for the development, ...

A recent study links chemotherapy to impaired ovarian function and fertility through oxidative damage to ovarian follicles.

Your dermatologist or oncologist may have told you what type of advanced squamous cell carcinoma you have. Here’s what each type means: Locally advanced squamous cell carcinoma: This means cancer has ...

A ₹3.5 crore Madhya Pradesh-funded study on cow dung and urine as cancer treatment raises questions over scientific validity, ...

A new study reveals how a single cancer protein may simultaneously drive tumor survival and metabolic control, uncovering a ...

AbbVie (NYSE: ABBV) and RemeGen today announced an exclusive licensing agreement for the development, manufacturing and commercialization of RC148, a novel investigational Programmed Cell Death-1 ...

A new kind of microscope is giving scientists a way to watch life inside cells with a clarity that feels almost unfair.

Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...

Immune checkpoint inhibitors (ICIs), including antibodies against the programmed cell death protein 1/ligand 1 (PD-1/L1) ...